Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Abramson Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Employees: -

Market Cap: -

Website: http://www.pennmedicine.org

Clinical Trials

Increasing Screening for Cancer Using EHR-Nudges Replication

Not Applicable

Conditions: Breast Cancer

First Posted Date: 2025-05-29

Last Posted Date: 2025-06-05

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 7920

Registration Number: NCT06995703

Locations: 🇺🇸
Lancaster General Health, Lancaster, Pennsylvania, United States

Healthy Volunteers Study

Recruiting

Conditions: Ovarian Cancer
Genetic Predisposition to Disease

First Posted Date: 2025-05-08

Last Posted Date: 2025-05-08

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 50

Registration Number: NCT06962059

Locations: 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Evaluating a Bidirectional Priming Intervention for Goals-of-care Communication in Oncology

Not Applicable

Not yet recruiting

Conditions: Lung Cancers
Gastrointestinal Cancers

First Posted Date: 2025-05-02

Last Posted Date: 2025-05-02

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 80

Registration Number: NCT06955468

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Practical Geriatric Assessment (PGA) Implementation Strategies and Correlative Evaluations (PACE-70)

Not yet recruiting

Conditions: Geriatric Assessment
Advanced Cancer
Toxicity

First Posted Date: 2025-03-11

Last Posted Date: 2025-06-08

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 150

Registration Number: NCT06870617

Locations: 🇺🇸
Penn Medicine Princeton Medical Center, Princeton, New Jersey, United States
🇺🇸
Lancaster General Hospital, Lancaster, Pennsylvania, United States
🇺🇸
Pennsylvania Hospital, Philadelphia, Pennsylvania, United States

Photobiomodulation in Head and Neck Cancer-Related Chronic Lymphedema

Not Applicable

Not yet recruiting

Conditions: Head and Neck Cancer
Lymphedema of the Head and Neck

First Posted Date: 2025-02-20

Last Posted Date: 2025-05-22

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 150

Registration Number: NCT06837480

Locations: 🇺🇸
University of Pennsylvania Abramson Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Head Stabilization in Whole Brain RT

Not Applicable

Not yet recruiting

Conditions: Brain Cancer

First Posted Date: 2025-01-15

Last Posted Date: 2025-04-11

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 20

Registration Number: NCT06776406

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Consolidative Metastasis and Primary Directed Therapy (MPDT) for Renal Cell Carcinoma (RCC)

Phase 2

Not yet recruiting

Conditions: Renal Cell Carcinoma

First Posted Date: 2025-01-13

Last Posted Date: 2025-02-11

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 23

Registration Number: NCT06770855

Locations: 🇺🇸
Abramson Cancer Center at University of Pennsylvania, Philadelphia, Pennsylvania, United States

Maintenance Niraparib Plus Ipilimumab in Patients With Metastatic Pancreatic Adenocarcinoma Whose Disease Has Not Progressed on Platinum-Based Chemotherapy

Phase 2

Recruiting

Conditions: Pancreatic Adenocarcinoma Metastatic

Interventions: Drug: Niraparib
Drug: FOLFIRI
Drug: Ipilimumab

First Posted Date: 2024-12-24

Last Posted Date: 2025-05-13

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 68

Registration Number: NCT06747845

Locations: 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
University of Pennsylvania, Abramson Cancer Center, Philadelphia, Pennsylvania, United States

Patient Ambassador

Not Applicable

Conditions: Gynecologic Cancer

First Posted Date: 2024-12-02

Last Posted Date: 2024-12-02

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 23

Registration Number: NCT06711380

Locations: 🇺🇸
Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania, United States

Assessing Perceptions of ML Explanations by Medical Oncologists

Not Applicable

Conditions: Oncology

First Posted Date: 2024-11-21

Last Posted Date: 2025-01-31

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 50

Registration Number: NCT06699615

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy